How rival weight-loss drugs fare at treating obesity, diabetes and more Obesity drugs have another superpower: taming inflammation Game-changing obesity drugs go mainstream: what scientists are learning Two types of fibroblast drive arthritis Subjects Obesity Medical research Ageing Latest on: Obesity Medical research Ageing The latest benefit of obesity drugs: boosting testosterone and sperm quality News Obesity doesnt equate to ill health: why the disease label doesnt always fit Comment A deep-learning framework reveals whole-body perturbations at cell level Article Personalized gene therapy relieves severe epilepsy in two boys Research Highlight New hope in the fight against cachexia cancers deadly co-conspirator News Feature Mans ability to make sperm restored after testicular tissue transplant: what scientists think News Could this mysterious disappearing organ hold the key to longevity
Conversely, the most common side effects associated with treatment for obesity and type 2 diabetes with GLP-1 analogs are nausea and vomiting
The results come from CT388-103, a randomized, double-blind, placebo-controlled Phase II trial
Kenny HA, Lal-Nag M, White EA, Shen M, Chiang CY, Mitra AK, et al
However, not everyone will be eligible
